summary
Introduced
02/27/2025
02/27/2025
In Committee
04/16/2025
04/16/2025
Crossed Over
Passed
Dead
Introduced Session
2025 Legislative Measures
Bill Summary
The statement includes a measure digest written in compliance with applicable readability standards. Digest: The Act tells OHA and DVA to study the use of ibogaine by some people to help treat certain disorders. (Flesch Readability Score: 68.0). Digest: The Act tells OHA and DVA to set up a process to let a person with a certain disorder use ibogaine to help treat the disorder. (Flesch Readability Score: 63.3). Directs the Oregon Health Authority in collaboration with and the Department of Veterans’ Affairs to establish a process through which a certain individual may consume ibogaine for a specified purpose study the consumption of ibogaine by certain individuals for the purpose of treating specified disorders . Defines “ibogaine.” Requires the authority and the department to submit a report to the interim committees of the Legislative Assembly related to health care and veterans not later than September 15, 2029. Exempts ibogaine, when obtained and consumed through the es- tablished process, from the definition of “controlled substance.” Sunsets on January 2, 2030.
AI Summary
This bill directs the Oregon Health Authority (OHA) and Department of Veterans' Affairs (DVA) to conduct a comprehensive study on ibogaine, a naturally occurring psychoactive substance extracted from the Tabernanthe iboga shrub, as a potential treatment for several mental health and substance use disorders, including post-traumatic stress disorder, major depressive disorder, anxiety disorder, and substance use disorder. The study will investigate multiple aspects of ibogaine use, including medical research, safety, sourcing, recommended dosages, administration methods, client screening, safety protocols, practitioner training, client support, tracking systems, and potential funding mechanisms. The agencies are required to submit a detailed report to the legislative committees related to health care by September 15, 2029, which may include recommendations for future legislation. The bill includes a sunset provision, meaning the study and associated provisions will automatically be repealed on January 2, 2030, effectively creating a time-limited research initiative to explore the potential therapeutic applications of ibogaine in a controlled, systematic manner.
Committee Categories
Budget and Finance, Health and Social Services
Sponsors (9)
Alek Skarlatos (R)*,
David Smith (R)*,
Willy Chotzen (D),
Darin Harbick (R),
Rick Lewis (R),
John Lively (D),
Werner Reschke (R),
Bruce Starr (R),
Kim Thatcher (R),
Last Action
Referred to Ways and Means by order of Speaker. (on 04/16/2025)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...